Brief: Galera Therapeutics Reports Q4 And FY2020 Financial Results
March 11 (Reuters) - Galera Therapeutics Inc GRTX.O :
* GALERA THERAPEUTICS REPORTS FOURTH QUARTER AND FULL YEAR
2020
FINANCIAL RESULTS AND RECENT ACCOMPLISHMENTS
* Q4 LOSS PER SHARE $0.80
* Q4 EARNINGS PER SHARE ESTIMATE $-0.71 -- REFINITIV IBES
DATA
* GALERA - EXPECTS EXISTING CASH, CASH EQUIVALENTS &
SHORT-TERM
INVESTMENTS WILL ENABLE TO FUND OPERATING EXPENSES & CAPEX
REQUIREMENTS INTO H2 2022
Source text for Eikon: ID:nGNX9fJN6x
Further company coverage: GRTX.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Galera Therapeutics
See all newsBrief: Galera Therapeutics Says Nasdaq Will Delist Co's Common Stock By Filing Form 25 With SEC On Sept 4
Brief: Galera Announces Board Approval Of Complete Liquidation And Dissolution
Brief: Galera Therapeutics Receives Written Notice From Nasdaq Indicating That Nasdaq Hearings Panel Determined To Delist Co’s Shares
Brief: Alpha Pharma Investments Llc Reports 10.899% Passive Stake In Galera Therapeutics
Brief: Galera Adopts Limited Duration Stockholder Rights Agreement